Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,937 | -15,851 | -9,895 | -6,676 | -4,301 |
| Depreciation Amortization | 2 | 4 | 3 | 2 | 1 |
| Accounts payable and accrued liabilities | 578 | 1,543 | -267 | -935 | 373 |
| Other Working Capital | 284 | 1,845 | -926 | -1,995 | 996 |
| Other Operating Activity | -575 | -1,352 | 326 | 1,019 | -310 |
| Operating Cash Flow | $-4,649 | $-13,811 | $-10,759 | $-8,585 | $-3,242 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -18 | N/A | N/A | N/A |
| Investing Cash Flow | $-6 | $-18 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 501 | 14,050 | 13,548 | 13,548 | 9,033 |
| Other Financing Activity | -96 | 519 | 614 | 706 | 795 |
| Financing Cash Flow | $405 | $14,569 | $14,162 | $14,254 | $9,828 |
| Beginning Cash Position | 7,201 | 6,461 | 6,461 | 6,461 | 6,461 |
| End Cash Position | 2,951 | 7,201 | 9,864 | 12,130 | 13,048 |
| Net Cash Flow | $-4,250 | $740 | $3,403 | $5,669 | $6,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,649 | -13,811 | -10,759 | -8,585 | -3,242 |
| Capital Expenditure | -6 | -18 | N/A | N/A | N/A |
| Free Cash Flow | -4,655 | -13,829 | -10,759 | -8,585 | -3,242 |